Biophore India Pharma gets CDSCO nod to manufacture, market Cannabidiol in India

Cannabidiol by Zenara and Biophore has been filed with the USFDA and is awaiting approval.

This is the first time ever that a Cannabidiol-based product has been approved in India delivering a unique therapy option. The product is being manufactured at USFDA and EU approved state-of-the-art facilities in Hyderabad and Vishakhapatnam, it said.

Jagadeesh Babu Rangisetty, CEO, Biophore, said, "The approval of this product is in line with our vision to bring world-class products to the Indian market. It has been an intense journey over the past few years on the development programme of this product, both the active ingredient and the final product, and we are really excited to get the green light. We continue to invest in such first-of-its-kind products for the Indian market and we will see more of such in the coming years."